You are here

  • Home
  • Archive
  • Volume 76, Issue 2
  • Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives

Article metrics

Article menu

Download PDFPDF

XML
State of the art review
Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2024

AbstractFullPdf
Dec 2020475461366
Jan 202113411324147
Feb 2021345328115
Mar 202126825965
Apr 202115615556
May 202118017837
Jun 202112211647
Jul 202113713650
Aug 20211059641
Sep 2021959340
Oct 202113211557
Nov 2021686536
Dec 2021926926
Jan 2022818136
Feb 2022757510
Mar 2022768016
Apr 2022596321
May 2022626220
Jun 2022535514
Jul 202239368
Aug 2022555213
Sep 2022655719
Oct 2022878220
Nov 202239368
Dec 2022514910
Jan 2023292510
Feb 202344435
Mar 202355529
Apr 202323229
May 2023242311
Jun 202327266
Jul 202320208
Aug 202319196
Sep 202327284
Oct 202323223
Nov 202323234
Dec 202327276
Jan 202419192
Feb 202430309
Mar 20242928153
Total467745301523